EVROF — Evrofarma Viomichania Galaktos Anonymi Viomichaniki & Emporiki Etaireia SA Share News
0.000.00%
Last trade - 00:00- €51.10m
- €63.48m
- €49.44m
Brief: Evrofarma FY 2025 Net Profit At EUR 3.5 Million, Up 55% YoY
Brief: Evrofarma H1 Net Profit At EUR 1.8 Million
Brief: Evrofarma FY 2024 Net Profit At EUR 2.3 Million Versus EUR 2.2 Million Year Ago
Brief: Evrofarma Issues EUR 9.95 Million Bond Loan
Brief: Evrofarma H1 Net Profit At EUR 1.4 Million
Brief: Evrofarma FY 2023 Net Profit At EUR 2.2 Million, Up 55% YoY
Brief: Evrofarma FY Result Turns To Net Profit Of EUR 1.4 Million
Brief: Evrofarma 9-Month Profit Before Tax Up At EUR 0.7 Million YoY
Brief: Evrofarma H1 Net Result Turns To Loss Of EUR 0.02 Million
Brief: Evrofarma FY Net Loss At EUR 0.4 Million
Brief: Evrofarma Will Not Distribute Dividend For FY 2021
Brief: Evrofarma Q3 Result Turns To Loss Before Tax Of EUR 0.3 Million
Brief: Evrofarma H1 Net Profit Up At EUR 0.7 Million
Brief: Evrofarma Appoints Paschalis Papazilakis Chairman And CEO
Brief: Evrofarma FY Profit After Taxes Widens To EUR 1.0 Million YoY
Brief: Evrofarma Announces New Chief Financial Officer
Brief: Evrofarma BOD Proposes To AGM Not To Distribute Dividend For FY 2020
Brief: Evrofarma Issues 5-Year Common Bond Loan Of EUR 2.9 Million
Brief: Evrofarma Q3 Result Turn To Profit Before Tax of EUR 0.4 Million